Home Healthcare Biotechnology Clinical Oncology Next Generation Sequencing Market

Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Applications (Screening, Companion Diagnostics, Others), By Workflow (NGS Pre Sequencing, NGS Sequencing, NGS Data Analysis), By Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequence And Re-Sequencing), By End-User (Hospitals, Diagnostic laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Clinical Oncology Next Generation Sequencing Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Screening
    2. Companion Diagnostics
    3. Others
  2. Clinical Oncology Next Generation Sequencing Market, By Workflow 2022-2034 (USD MILLION/ Units)
    1. NGS Pre Sequencing
    2. NGS Sequencing
    3. NGS Data Analysis
  3. Clinical Oncology Next Generation Sequencing Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Whole Genome Sequencing
    2. Whole Exome Sequencing
    3. Targeted Sequence And Re-Sequencing
  4. Clinical Oncology Next Generation Sequencing Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Diagnostic laboratories
    3. Others
  5. Regional Clinical Oncology Next Generation Sequencing Market
    1. North America
      1. North America Clinical Oncology Next Generation Sequencing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Screening
        2. Companion Diagnostics
        3. Others
      2. North America Clinical Oncology Next Generation Sequencing Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. NGS Pre Sequencing
        2. NGS Sequencing
        3. NGS Data Analysis
      3. North America Clinical Oncology Next Generation Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Whole Genome Sequencing
        2. Whole Exome Sequencing
        3. Targeted Sequence And Re-Sequencing
      4. North America Clinical Oncology Next Generation Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic laboratories
        3. Others
      5. U.S.
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      6. Canada
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
    2. Europe
      1. Europe Clinical Oncology Next Generation Sequencing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Screening
        2. Companion Diagnostics
        3. Others
      2. Europe Clinical Oncology Next Generation Sequencing Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. NGS Pre Sequencing
        2. NGS Sequencing
        3. NGS Data Analysis
      3. Europe Clinical Oncology Next Generation Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Whole Genome Sequencing
        2. Whole Exome Sequencing
        3. Targeted Sequence And Re-Sequencing
      4. Europe Clinical Oncology Next Generation Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic laboratories
        3. Others
      5. U.K.
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      6. Germany
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      7. France
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      8. Spain
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      9. Italy
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      10. Russia
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      11. Nordic
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      12. Benelux
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      13. Rest of Europe
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
    3. APAC
      1. APAC Clinical Oncology Next Generation Sequencing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Screening
        2. Companion Diagnostics
        3. Others
      2. APAC Clinical Oncology Next Generation Sequencing Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. NGS Pre Sequencing
        2. NGS Sequencing
        3. NGS Data Analysis
      3. APAC Clinical Oncology Next Generation Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Whole Genome Sequencing
        2. Whole Exome Sequencing
        3. Targeted Sequence And Re-Sequencing
      4. APAC Clinical Oncology Next Generation Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic laboratories
        3. Others
      5. China
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      6. Korea
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      7. Japan
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      8. India
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      9. Australia
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      10. Taiwan
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      11. South East Asia
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      12. Rest of Asia-Pacific
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
    4. Middle East and Africa
      1. Middle East and Africa Clinical Oncology Next Generation Sequencing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Screening
        2. Companion Diagnostics
        3. Others
      2. Middle East and Africa Clinical Oncology Next Generation Sequencing Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. NGS Pre Sequencing
        2. NGS Sequencing
        3. NGS Data Analysis
      3. Middle East and Africa Clinical Oncology Next Generation Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Whole Genome Sequencing
        2. Whole Exome Sequencing
        3. Targeted Sequence And Re-Sequencing
      4. Middle East and Africa Clinical Oncology Next Generation Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic laboratories
        3. Others
      5. UAE
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      6. Turkey
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      7. Saudi Arabia
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      8. South Africa
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      9. Egypt
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      10. Nigeria
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      11. Rest of MEA
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
    5. LATAM
      1. LATAM Clinical Oncology Next Generation Sequencing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Screening
        2. Companion Diagnostics
        3. Others
      2. LATAM Clinical Oncology Next Generation Sequencing Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. NGS Pre Sequencing
        2. NGS Sequencing
        3. NGS Data Analysis
      3. LATAM Clinical Oncology Next Generation Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Whole Genome Sequencing
        2. Whole Exome Sequencing
        3. Targeted Sequence And Re-Sequencing
      4. LATAM Clinical Oncology Next Generation Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic laboratories
        3. Others
      5. Brazil
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      6. Mexico
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      7. Argentina
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      8. Chile
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      9. Colombia
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
      10. Rest of LATAM
        1. Screening
        2. Companion Diagnostics
        3. Others
        4. NGS Pre Sequencing
        5. NGS Sequencing
        6. NGS Data Analysis
        7. Whole Genome Sequencing
        8. Whole Exome Sequencing
        9. Targeted Sequence And Re-Sequencing
        10. Hospitals
        11. Diagnostic laboratories
        12. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.